We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

92 hedge funds and large institutions have $99M invested in Palvella Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $93M → $99M (+$5.96M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.06% less ownership

Funds ownership: 0.81% → 0.75% (-0.06%)

6% less funds holding

Funds holding: 98 → 92 (-6)

27% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 30

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
22
Reduced
30
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TA
Teachers Advisors
New York
+$1.21M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$498K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$436K
4
GIP
Granite Investment Partners
California
+$393K
5
American Century Companies
American Century Companies
Missouri
+$331K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$10.1M
2
SFM
Sphera Funds Management
Israel
-$1.86M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.07M
4
Millennium Management
Millennium Management
New York
-$1.06M
5
PM
Prosight Management
Texas
-$885K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$964K +$436K +1,837 +104%
OAM
27
Oxford Asset Management
United Kingdom
$913K -$444K -1,871 -35%
PAWC
28
P.A.W. Capital
Connecticut
$838K -$148K -625 -17%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$830K -$124K -522 -14%
Charles Schwab
30
Charles Schwab
California
$762K +$39.2K +165 +6%
AllianceBernstein
31
AllianceBernstein
Tennessee
$751K -$22.6K -95 -3%
FI
32
Fosun International
China
$710K +$104K +438 +19%
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$690K – – –
Cerity Partners
34
Cerity Partners
New York
$638K – – –
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$562K +$498K +2,098 New
6CM
36
683 Capital Management
New York
$503K – – –
SSA
37
Schonfeld Strategic Advisors
New York
$503K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$461K -$90.3K -380 -18%
GIP
39
Granite Investment Partners
California
$443K +$393K +1,654 New
Two Sigma Advisers
40
Two Sigma Advisers
New York
$404K -$4.04K -17 -1%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$384K – – –
SO
42
STRS Ohio
Ohio
$351K – – –
JC
43
JBF Capital
Colorado
$335K – – –
DS
44
DRW Securities
Illinois
$335K +$297K +1,250 New
GCP
45
GSA Capital Partners
United Kingdom
$326K -$63.7K -268 -18%
Wells Fargo
46
Wells Fargo
California
$317K -$2.14K -9 -0.8%
Creative Planning
47
Creative Planning
Kansas
$299K +$950 +4 +0.4%
FQ
48
First Quadrant
California
$294K -$206K -866 -44%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$273K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$257K -$336K -1,415 -60%
1
2
3 4 5

PVLA Hedge Fund Activity: Q1 2019 in Review

92 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q1 2019, worth a combined $99M — up 6.4% from $93M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PVLA and 7 opened new positions — a net loss of 6 holders — while 30 trimmed existing stakes and 22 added.

The largest buyer was Teachers Advisors, adding an estimated $1.21M. The largest seller was BVF Inc, cutting an estimated $10.1M.

  • 92 institutional investors held Palvella Therapeutics (PVLA) as of Q1 2019, down from 98 in Q4 2018.
  • Funds reported $99M of Palvella Therapeutics stock for Q1 2019, up 6.4% quarter-over-quarter.
  • 7 funds opened new Palvella Therapeutics positions in Q1 2019 and 13 closed out, a net change of -6 holders.
  • The largest Palvella Therapeutics buyer in Q1 2019 was Teachers Advisors, an estimated $1.21M added.
  • The largest Palvella Therapeutics seller in Q1 2019 was BVF Inc, an estimated $10.1M sold.

Based on aggregated 13F filings for Q1 2019.